Parexel Acquires Turkish CROBy
The contract research organization Parexel International Corporation has acquired all of the outstanding equity securities of Atlas Medical Services, a provider of clinical research services in Turkey, the Middle East, and North Africa.
Atlas provides services across all phases of clinical development and has therapeutic expertise in oncology, hematology, endocrinology, cardiovascular, anesthesiology, infectious diseases and the central nervous system. The firm also provides clinical trial-related services from study planning and feasibility, through site selection, data management, medical writing, and regulatory services supporting product registration.
Atlas was founded in 2005, and works with more than 28 biopharmaceutical services companies The company has 35 employees and is headquartered in Istanbul, with additional offices in Ankara and Izmir. The business will be integrated into PAREXEL's Clinical Research Services business. Atlas had 2013 revenues of approximately $4 million.